N/A N=133 Mechanisms of Upper Airway Obstruction
Obstructive Sleep Apnea
Primary: Pharyngeal Critical Pressure (Pcrit) — 1.26; -1.42; -1.06 cm H2O — p=.80
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=164 Soiled Airway Tracheal Intubation and the Effectiveness of Decontamination by Paramedics
Airway Management · Intubation, Intratracheal · Laryngoscopy
Primary: Difference in First-pass Intubation Success Rates Before and After SALAD Training — 44; 74 Participants
N/A N=56 The Articulated Oral Airway as an Aid to Mask Ventilation
Mask Ventilation · Airway Obstruction Upper · Airway Management
Primary: Expiratory Tidal Volume (Breaths 6-10) — 4.46; 3.21; 3.12; 3.48 ml/kg
N/A N=37 Biocontainment Device for Aerosol Generating Procedures
Protective Device (Physical Object) · Aerosol Disease · Droplet Spread
Primary: Measuring the Time for Performing an Airway Procedure With or Without the Biocontainment Device. — 46; 37 time (seconds)
N/A N=40 Use of Stable Airway Management Device in Monitored Anesthesia Care
Anesthesia
Primary: Total Apneic Events /Total Number Requiring Airway Manipulation — 2; 1 Number of airway manipulations
N/A N=3,004 Pragmatic Airway Resuscitation Trial
Cardiac Arrest
Primary: Number of Patients Alive at 72 Hours After Episode. — 230; 275 Participants
N/A N=76 Evaluating Air Leak Detection in Intubated Patients
Critical Care
Primary: CO2 Leakage Above the ETT Cuff, Measured Over Time. — 0.09; 0.22 [CO2 mmHg*hour]/hour
N/A N=112 Asthma Intervention Research (AIR) Trial
Asthma
Primary: Mild Exacerbation Rate (OFF-LABA) (Change From Baseline) — -0.16; 0.04 Exacerbations/Subject/Week
N/A N=225 Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial
Laryngeal Masks
Primary: Airway Seal Pressure After Device Placement — 28; 27; 24 cmH2O
N/A N=30 Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients
Swallowing Disorder · Aspiration · Long Term Ventilation
Primary: Muscle Strength — 20; 10 participants
N/A N=62 Impact of the Inspiratory Cortical Control on the Outcome of the Ventilatory Weaning Test in Patients Intubated in Resuscitation
Respiration Disorder · Respiratory Failure · Weaning Failure
Primary: Magnitude of Inspiratory Premotor Potentials — 1.2; 2.1 µV
N/A N=360 Apneic Oxygenation During Airway Management in Pediatric Patients
Hypoxia
Primary: Time to First Event: Pulse Oximetry at 95%, or Successful Intubation — 106; 169 seconds
N/A N=218 Clinical Comparison of the Airway Devices
Endotracheal Intubation · Supraglottic Airway
Primary: Duration of Intubation — 30.9; 30.8; 30.17 seconds
N/A N=297 Asthma Intervention Research 2 (AIR2) Trial
Asthma
Primary: Integrated Asthma Quality of Life Questionnaire (AQLQ) Score (Change From Baseline) — 1.35; 1.16 Units on a scale
Phase 4 N=198 Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management
Acute Respiratory Distress
Primary: First Pass Success in Patients Undergoing Emergency Intubation, Intubated With Either Direct Larynogoscopy or Video Laryngoscopy Using a C-MAC Device. — 86.3; 92.2…
N/A N=25 Neurostimulation for the Relief of Acute Bronchoconstriction
Asthma
Primary: Safety- Number of Participants With Adverse Events — 16 Participants
N/A N=566 Mode Of Ventilation During Critical IllnEss Pilot Trial
Respiratory Failure
Primary: Ventilator-free Days (VFDs) to Day 28 After Enrollment — 23; 22; 24 Ventilator-free days to day 28
N/A N=42 Novel Device to Assess Endotracheal Tube Migration
Mechanically Ventilated Patients Admitted to a MICU
Primary: Endotracheal Tube Displacement Bias Measured by a Novel Device (AirWave) Compared to CXR — -0.06; -0.29; 0.39 cm
Phase 2 N=65 Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
Parkinson's Disease · Dysphagia · Dystussia
Primary: Change in Voluntary Cough Peak Flow — 0.17; 0.51 l/s
Phase 4 N=100 Air-Q Intubating Laryngeal Airway Versus the Laryngeal Mask Airway (LMA)-Proseal
Difficult Airway · Anesthesia; Functional
Primary: Airway Seal Pressure — 30; 30 cmH2O
N/A N=101 Pentax Airway Scope (AWS) Intubation
Obesity
Primary: Time to Intubation — 26; 38 seconds — p=<0.001
N/A N=90 Tracheal Palpation of Sliding Cuff to Assess Endotracheal Tube Location
Anesthesia Intubation Complication
Primary: Sore Throat — 1.5; 0.6 units on a scale — p=0.04
N/A N=11 Sedation in Patients at Risk for Upper Airway Collapse
Obstructive Sleep Apnea
Primary: Respiratory Disturbance Index — 57.52; 21.32 events per hour
N/A N=59 Modulation Of Airway Reactivity With Chronic Mechanical Strain
Asthma
Primary: Change in Airway Reactivity From Baseline (Visit 1) and 4 Weeks (Visit 2) — 3.0; 3.2; 5.3; 4.3 mg/mL
N/A N=100 Comparison Study of Two Supraglottic Airway Devices Used for Patients Under General Anesthesia
Anesthesia Airway Management
Primary: Measure of the Airway Leak Pressure — 23; 21 cmH2O
N/A N=450 A New Insertion Technique for Laryngeal Mask Airway
Airway Morbidity
Primary: Number of Subjects Who Present With Postoperative Sore Throat — 71; 71; 67 Participants
N/A N=16 Prospective Use of Awake Endoscopy for Inspire Activation
Obstructive Sleep Apnea
Primary: Distribution of Electrode Configurations Resulting in Greatest Retropalatal Expansion Among Cohort Subjects — 7; 3; 3; 2 Participants
N/A N=228 Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
Et Control Performance in Adult Population Surgery
Primary: Percent Duration Without Large Deviation of End-Tidal Anesthetic Agent (EtAA) Based on Extraction Algorithm (ALG) — 91.7; 80.8 percent duration — p=<.001
N/A N=119 Airway Protective Mechanisms in PD (R01)
Parkinson Disease
Primary: Respiratory Sensitivity — 0.22; 0.22; 0.21; 0.22 scores on a scale / CmH2O — p=<.0001
Phase 4 N=81 Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block
Airway Reflexes, Protective · Recovery After Neuromuscular Block · Anesthetic Recovery
Primary: Recovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis. — 16; 25; 10; 6 participants — p=0.11